Phebra continues international business expansion

Australia |  News | 0 Comment | 24 May, 2019

Australian pharmaceutical firm Phebra has continued its international business expansion with the opening of its subsidiary in Montreal, Canada. The new entity, Phebra Canada, will be ...Read more

FDA approves SORILUX(R) for Adolescent Plaque Psoriasis

Australia |  News | 0 Comment | 23 May, 2019

Mayne Pharma Group Limited has announced that the US Food and Drug Administration (FDA) has approved SORILUX® (calcipotriene) Foam, 0.005% in adolescents. SORILUX is now approved ...Read more

Microsoft provides grant to develop Epilepsy prediction device

Australia |  News | 0 Comment | 21 May, 2019

The University of Sydney's Faculty of Engineering and Information Technologies has been awarded an AI for Accessibility grant from Microsoft to support its efforts developing solutions that...Read more

Scientists find ‘molecular destruction code’ for enzyme involved in cholesterol production

Australia |  News | 0 Comment | 20 May, 2019

A team of UNSW scientists at the School of Biotechnology and Biomolecular Sciences led by Professor Andrew Brown have shown how a key enzyme that contributes to cholesterol production can b...Read more

Kazia enters clinical collaboration for metastatic brain cancer

Australia |  News | 0 Comment | 20 May, 2019

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials in On...Read more

BGI Genomics, Pryzm Health to advance precision public health

Australia |  News | 0 Comment | 15 May, 2019

BGI Genomics and digital health start-up, Pryzm Health (Pryzm), have signed a Memorandum of Understanding (MoU)  for collaboration to advance precision public health in Austr...Read more

UNSW study predicts more than 50% rise in chemotherapy demand by 2040

Australia |  News | 0 Comment | 14 May, 2019

A new study predicts that between 2018 and 2040, the number of patients needing chemotherapy each year will rise from 9.8 million to 15 million globally – a 53% increase. The research...Read more

TGA approves SpeeDx Respiratory Virus Test

Australia |  News | 0 Comment | 14 May, 2019

SpeeDx Pty. Ltd. has announced the clearance of the PlexPCR® RespiVirus* test from the Australian Therapeutic Goods Administration (TGA). The test utilises market-leading PlexPCR® t...Read more

AIMed and BCS collaborate to launch AIMed Australia

Australia |  News | 0 Comment | 13 May, 2019

AIMed, a leading provider of global clinician-led artificial intelligence events, education and editorial content in healthcare and medicine has announced a new partnership with Best Case S...Read more

Industry key to boosting health and medical research

Australia |  News | 0 Comment | 10 May, 2019

Creating a business environment that better supports emerging and cutting-edge technologies along the pathway from discovery, through clinical trials, to patients is essential. The health ...Read more

Kazia Therapeutics calls for greater awareness of the most lethal women's disease in India

Australia |  News | 0 Comment | 08 May, 2019

This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd calls for greater awareness of what is the most lethal women's disease in Au...Read more

Micromon Genomics starts using MGI's MGISEQ-2000 genetic sequencer

Australia |  News | 0 Comment | 03 May, 2019

MGI, a division of global genomics leader BGI Group has announced that Micromon Genomics is the first Australian commercial user of its high-throughput genetic sequencer MGISEQ-2000. Monash...Read more

AXT offers Organ-on-Chip systems in Asia Pacific region

Australia |  News | 0 Comment | 06 May, 2019

Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia’s supplier of high technology scientific equipment. The agreement will s...Read more

International Stem Cell Corporation completes enrollment in its Parkinson's Disease clinical trial

Australia |  News | 0 Comment | 30 Apr, 2019

International Stem Cell Corporation,  a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products has announced the comple...Read more

SmartGraft technology enters Australia

Australia |  News | 0 Comment | 29 Apr, 2019

SmartGraft, a minimally invasive and permanent hair restoration treatment from the U.S.A. is proud to announce their partnership with Samson Medical Technologies to introduce their innovati...Read more

EPS International and George Clinical put focus on APAC region

Australia |  News | 0 Comment | 26 Apr, 2019

George Clinical and EPS International Holdings Co., Ltd. announced that they have reached an agreement on a strategic partnership that will enhance their combined service offerings in ...Read more

SpeeDx receives funding from U.S. Venture Firm

Australia |  News | 0 Comment | 24 Apr, 2019

Australia based SpeeDx Pty. Ltd. has announced further series A funding received by new investor partners, Northpond Ventures, LP – a U.S.-based, formative stage venture capital fund ...Read more

CMD LLC wins AU$1 million grant award from FightMND

Australia |  News | 0 Comment | 18 Apr, 2019

Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases.  CMD has announced that it w...Read more